M/16/020 – Jaguar / Synexus
Transaction details
The proposed acquisition by Jaguar Holding Company I of sole control of Synexus Clinical Research Topco Limited has been cleared by the Competition and Consumer Protection Commission.
Notification date |
Decision date |
Wednesday April 13, 2016 |
Thursday, May 12, 2016 |
Parties Involved |
Business activities |
Jaguar Holding Company I. |
Jaguar Holding Company I,is a USA-based Holding Company.
|
Synexus Clinical Research Topco Limited |
The target, Synexus Clinical Research Topco Limited, is involved in managing pharmaceutical clinical trials.
|
Economic sector |
Media merger |
Pharmaceuticals |
No |
Submissions from third parties due by: |
Phase 1 |
Phase 2 |
Wednesday, April 27, 2016 |
|
Current status: Completed |
Cleared (Phase 1) |
Authorised Officer Assigned |
Contact Details |
Andrew Rae |
Tel: 470-3671 Email: andrewrae@ccpc.ie
|
Return to Merger Notifications
Join our mailing list
- Sign up for the latest information about mergers:
Haven’t found what you’re looking for?